Strategic VP, Investor Relations & Corporate Communications

Janux Therapeutics Inc.

United States

Ibrido

USD 180.000 - 230.000

Tempo pieno

5 giorni fa
Candidati tra i primi

Aumenta le possibilità di ricevere una risposta da questo datore di lavoro

Il tuo curriculum e una lettera di presentazione personalizzati, che corrispondono esattamente a ciò che sta cercando.

Supera i filtri ATS

Vantaggi offerti da questo lavoro

Annual bonus program
Incentive stock options
401k with employer contribution
Medical, dental, vision insurance
HSA/FSA and supplemental plans
Unlimited PTO
Generous holidays
Relocation assistance

Descrizione del lavoro

Janux Therapeutics, Inc. is seeking a senior leader for investor relations and corporate communications to shape the company’s narrative, strategy, and credibility with investors, analysts, and media.

You will own messaging frameworks, positioning, and external communications across earnings, regulatory updates, and corporate milestones. In this hybrid role based in the United States, you will build relationships with institutional investors, lead conferences and roadshows, coordinate with Legal

Competenze

  • 12-15 years of progressive leadership experience in investor relations and/or corporate communications within biotechnology, pharma, or life sciences.
  • Significant oncology experience with experience supporting innovative therapeutic platforms and complex modalities.
  • Exceptional communication skills with ability to translate complex scientific and business developments into clear narratives.
  • Strong understanding of capital markets, investor behavior, and biotech valuation drivers.
  • Established relationships with key investors, analysts, and media in healthcare/life sciences.

Mansioni

  • Develop and execute IR and corporate communications strategy aligned with Janux's mission, pipeline priorities, and business objectives.
  • Shape corporate narrative, branding, messaging frameworks, and visibility across stakeholders.
  • Lead investor engagement activities including conferences, roadshows, and investor days.
  • Prepare leadership for investor interactions with messaging, FAQs, Q&A materials, and briefing packs.
  • Oversee earnings materials, investor presentations, press releases, website content, and speaking points.

Conoscenze

Investor relations leadership
Corporate communications
Strategic storytelling
Financial communications
Stakeholder engagement

Formazione

Bachelor's degree in Finance/Biology/Communications or related field
MBA/PhD/MS preferred

Strumenti

IR platforms

Descrizione del lavoro

Janux Therapeutics, Inc. is seeking a senior leader for investor relations and corporate communications to shape the company’s narrative, strategy, and credibility with investors, analysts, and media.

You will own messaging frameworks, positioning, and external communications across earnings, regulatory updates, and corporate milestones. In this hybrid role based in the United States, you will build relationships with institutional investors, lead conferences and roadshows, coordinate with Legal

Ottieni la revisione del curriculum gratis e riservata.

o trascina qui il file.

Similar jobs

Offerte di lavoro simili che vale la pena confrontare

Biotech IR & Corporate Communications Leader (Hybrid/Remote)
Biotech IR & Corporate Communications Leader (Hybrid/Remote)

Janux Therapeutics, Inc. • San Diego (CA)

Ibrido
USD 317.000 - 347.000
Annual bonus program
Incentive stock options
401k plan with company contribution
+5
Remote VP, Investor Relations & Corporate Communications
Remote VP, Investor Relations & Corporate Communications

Ladders • Stati Uniti

Remoto
USD 317.000 - 347.000
Annual bonus program
Incentive stock option plan
401k plan with employer contribution
+4
Vice President, Investor Relations & Corporate Communications
Vice President, Investor Relations & Corporate Communications

Janux Therapeutics Inc. • Stati Uniti

Ibrido
USD 180.000 - 230.000
Annual bonus program
Incentive stock options
401k with employer contribution
+5
VP, Investor Relations & Corporate Communications
VP, Investor Relations & Corporate Communications

Church & Dwight Co., Inc. • Princeton (ME)

Ibrido
USD 248.000 - 325.000
Medical
Dental
Vision
+5
Remote Senior VP, Biotech Corporate Communications
Remote Senior VP, Biotech Corporate Communications

Mineralys Therapeutics, Inc. • Stati Uniti

Remoto
USD 180.000 - 280.000
Strategic Director, Corporate & Investor Communications
Strategic Director, Corporate & Investor Communications

Xenon Pharmaceuticals Inc. • Boston (MA)

In loco
USD 215.100 - 240.300
Medical benefits
Stock options
Retirement savings
+3
VP, Investor Relations & Strategic Communications
VP, Investor Relations & Strategic Communications

Church & Dwight • Ewing Township (NJ)

Ibrido
USD 248.000 - 325.000
Medical insurance
Dental insurance
Vision insurance
+5
VP, Investor Relations & Communications (Hybrid)
VP, Investor Relations & Communications (Hybrid)

Church & Dwight Co., Inc. • Ewing Township (NJ)

Ibrido
USD 248.000 - 325.000
Medical insurance
Dental insurance
Vision insurance
+1
Senior Biotech IR & Corporate Communications Lead
Senior Biotech IR & Corporate Communications Lead

Ardelyx • Boston (MA)

In loco
USD 140.000 - 171.000
401(k) match
Parental leave
Organ/bone marrow leave
+3
VP, Corporate Communications — Biotech Strategic Leader
VP, Corporate Communications — Biotech Strategic Leader

NewAmsterdam Pharma Corporation • Pennsylvania

Ibrido
USD 180.000 - 240.000
Health insurance
Dental and vision coverage
Term life and disability coverage
+1